Doç. Dr. ANDAÇ SALMAN

Yayın Ağı

Makaleler 77

1. Biomarkers in Chronic Spontaneous Urticaria: Are We Ready for its Use in Clinical Practice?

Xiang Y., Hu M., Elieh-Ali-komi D., SALMAN A., Smola A., Kocatürk E.

Current Treatment Options in Allergy , cilt.12, sa.1, 2025 (ESCI, Scopus)

2. Low Total IgE Predicts Non-Response to Omalizumab in Chronic Spontaneous Urticaria: A 10-Year Real-Life Study.

Yegin Katran Z., Bulut İ., Salman A.

International archives of allergy and immunology , ss.1-21, 2025 (SCI-Expanded, Scopus)

3. Tenoxicam-induced Fixed Drug Eruption Confirmed by Patch Testing

Akin Cakici O., UZUNÇAKMAK T. K., SALMAN A.

Asthma Allergy Immunology , cilt.23, sa.2, ss.180-182, 2025 (ESCI, Scopus)

4. Clinical Evaluation and Outcome Measures of Chronic Spontaneous Urticaria and Chronic Inducible Urticaria.

Weller K., Podder I., Salman A., Gimenez-Arnau A. M., Neisinger S., Altrichter S.

The journal of allergy and clinical immunology. In practice , 2025 (SCI-Expanded, Scopus)

5. Morgellons Disease as a Delusional Parasitosis: A Case Presenting with Dermatological and Ocular Symptoms

DOKUZ G., SALMAN A., YORGUNER N.

JOURNAL OF PSYCHIATRIC PRACTICE , cilt.31, sa.4, ss.227-229, 2025 (SCI-Expanded, Scopus)

6. Spectrum and Impact of Reported Side Effects of Omalizumab in Patients With Chronic Urticaria: A Long-Term Multicentre Real-World Study.

Soegiharto R., Van der Wind E., Alizadeh Aghdam M., Sørensen J. A., Van Lindonk E., Bulut Demir F., et al.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology , 2025 (SCI-Expanded, Scopus)

7. Remibrutinib in Chronic Spontaneous Urticaria.

Metz M., Giménez-Arnau A., Hide M., Lebwohl M., Mosnaim G., Saini S., et al.

The New England journal of medicine , cilt.392, sa.10, ss.984-994, 2025 (SCI-Expanded, Scopus)

8. Omalizumab is effective and safe in chronic inducible urticaria (CIndU): Real-world data from a large multi-national UCARE study

Soegiharto R., Alizadeh Aghdam M., Sørensen J., van Lindonk E., Bulut Demir F., Mohammad Porras N., et al.

Allergy: European Journal of Allergy and Clinical Immunology , cilt.80, sa.2, ss.489-499, 2025 (SCI-Expanded, Scopus)

9. Filaggrin Gene Variants Among Patients With Atopic Dermatitis in Turkey: A Multicenter Study Investigating Its Relationship With Disease Severity and Clinical/Laboratory Findings

ERDEM Y., ÖZKAYA E., ERBİLGİN Y., Saritas M., SAYİTOĞLU M., Kucuk O. S., et al.

DERMATITIS , 2025 (SCI-Expanded, Scopus)

10. Listening to Urticaria Patients Through Social Media: Analyzing the Impact of the COVID-19 Pandemic

TÜRK M., Baysal B., Ertas R., SALMAN A., Kocaturk E.

Asthma Allergy Immunology , cilt.23, sa.1, ss.86-95, 2025 (ESCI, Scopus) Sürdürülebilir Kalkınma

11. Biological drugs for the treatment of children with chronic spontaneous urticaria.

Podder I., Salman A., Asero R., Teresa Caballero M., Caffarelli C., De Las Vecillas L., et al.

Expert review of clinical immunology , cilt.20, sa.12, ss.1427-1435, 2024 (SCI-Expanded)

12. Psychological Stress and Urticaria: Pathophysiologic and Therapeutic Updates

Xiang Y., TÜRK M., Ojeda I. C., Elieh-Ali-Komi D., SALMAN A., Kocatuerk E.

CURRENT TREATMENT OPTIONS IN ALLERGY , cilt.11, sa.4, ss.194-210, 2024 (ESCI, Scopus)

13. UCOMB-real life data: treatment strategies for chronic urticaria patients with comorbidities.

Staubach P., Bilo B., Fluhr J. W., Krause K., Kulthanan K., Salman A., et al.

The Journal of dermatological treatment , cilt.35, sa.1, ss.2329784, 2024 (SCI-Expanded, Scopus)

14. Urticaria Beyond Omalizumab: What is Next?

Gimenez-Arnau A. M., SALMAN A.

Current Treatment Options in Allergy , cilt.11, sa.3, ss.159-166, 2024 (ESCI, Scopus)

15. Multinational Drug Survival Study of Omalizumab in Patients With Chronic Urticaria and Potential Predictors for Discontinuation

Soegiharto R., Aghdam M. A., Sorensen J. A., van Lindonk E., Demir F. B., Porras N. M., et al.

JAMA DERMATOLOGY , cilt.160, sa.9, ss.927-935, 2024 (SCI-Expanded, Scopus)

16. Inflammatory cytokine levels and changes during omalizumab treatment in chronic spontaneous urticaria

Hosgoren-Tekin S., PEKER EYÜBOĞLU İ., AKKİPRİK M., Gimenez-Arnau A. M., SALMAN A.

ARCHIVES OF DERMATOLOGICAL RESEARCH , cilt.6, sa.6, 2024 (SCI-Expanded, Scopus)

17. Biomarkers to predict therapeutic response in chronic spontaneous urticaria: a review.

Gimenez-Arnau A. M., Salman A., Podder I.

European journal of dermatology : EJD , cilt.34, sa.1, ss.3-12, 2024 (SCI-Expanded, Scopus)

18. Emerging Systemic Treatment Options in Atopic Dermatitis

SALMAN A., Gimenez-Arnau A. M.

BALKAN MEDICAL JOURNAL , cilt.41, sa.4, ss.239-247, 2024 (SCI-Expanded, Scopus)

19. Urticaria Exacerbations and Adverse Reactions in Patients with Chronic Urticaria Receiving COVID-19 Vaccination: Results of the UCARE COVAC-CU Study.

Kocaturk E., Salameh P., Sarac E., Vera Ayala C. E., Thomsen S. F., Zuberbier T., et al.

The Journal of allergy and clinical immunology , 2023 (SCI-Expanded, Scopus)

20. Acute and Chronic Urticaria Diagnosis and Management Taking into Account Their Differences

Salman A., Porras N. M., Gimenez-Arnau A. M. M.

CURRENT TREATMENT OPTIONS IN ALLERGY , cilt.10, sa.2, ss.130-147, 2023 (ESCI, Scopus)

21. Symmetrical drug-related intertriginous and flexural exanthema-like eruption: An addition to the spectrum of coronavirus disease 2019-related cutaneous findings

Çakıcı Ö. A., GUDER S., Salman A., Ergun T.

Indian Journal of Dermatology, Venereology and Leprology , cilt.88, sa.6, ss.814-816, 2022 (SCI-Expanded, Scopus)

22. Real-life effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis

Salman A., Sengun O. A., Aktas M., Taskapan O.

DERMATOLOGIC THERAPY , cilt.35, sa.1, 2022 (SCI-Expanded, Scopus)

23. Remission of chronic spontaneous urticaria following omalizumab with gradually extended dosing intervals: Real-life data

Salman A., Aktas M., Sengun O. A.

AUSTRALASIAN JOURNAL OF DERMATOLOGY , cilt.62, sa.3, ss.398-402, 2021 (SCI-Expanded, Scopus)

24. Visual Dermatology: Koebner's Phenomenon Due to Wet Cupping Therapy

Gulus-Demirel B., Salman A.

JOURNAL OF CUTANEOUS MEDICINE AND SURGERY , cilt.25, sa.3, ss.333, 2021 (SCI-Expanded, Scopus)

25. Public interest in dermatologic symptoms, conditions, treatments, and procedures during the COVID-19 pandemic: Insights from Google Trends

Esen-Salman K., Akin-cakici O., KARDEŞ S., Salman A.

DERMATOLOGIC THERAPY , cilt.34, sa.2, 2021 (SCI-Expanded, SSCI, Scopus)

26. What determines the treatment persistence in paediatric psoriasis?

Salman A.

BRITISH JOURNAL OF DERMATOLOGY , cilt.184, sa.3, ss.387-388, 2021 (SCI-Expanded, Scopus)

27. The global impact of the COVID-19 pandemic on the management and course of chronic urticaria

Kocaturk E., Salman A., Cherrez-Ojeda I., Criado P. R., Peter J., Comert-Ozer E., et al.

ALLERGY , cilt.76, sa.3, ss.816-830, 2021 (SCI-Expanded, Scopus)

28. Yellow Urticaria

Cakici O. A., Sengun O. A., Tekin S. H., Salman A.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE , cilt.9, sa.1, ss.479-480, 2021 (SCI-Expanded, Scopus)

29. Comment on "Cling film for mobile phones to prevent cross-infection during the COVID-19 pandemic''

Salman A., Comert-Ozer E., Esen-Salman K.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY , cilt.84, sa.1, 2021 (SCI-Expanded, Scopus)

30. A case series and literature review of erythema palmare hereditarium (Lane's disease)

Ozer E. C., Demir G., Aktas M., Salman A.

INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY , cilt.87, sa.1, ss.64-66, 2021 (SCI-Expanded, Scopus)

31. Being an academic dermatologist in Turkey: Young academic dermatologists' perspectives on dermatology

SOLAK S. S., Salman A.

TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY , cilt.55, sa.1, ss.34-40, 2021 (ESCI, Scopus)

32. Omalizumab Treatment in Chronic Spontaneous Urticaria During Pregnancy: Report of A Case and Review of the Literature

Salman A., Aktas M.

ASTIM ALLERJI IMMUNOLOJI , cilt.19, sa.2, ss.114-117, 2021 (ESCI, TRDizin)

33. Phacomatosis pigmentokeratotica associated with unilateral toe walking due to short achilles tendon

SALMAN A., YÜCELTEN A. D., AKIN ÇAKICI Ö., ÜNVER O.

TURK DERMATOLOJI DERGISI , cilt.14, sa.4, ss.106-108, 2020 (ESCI, Scopus, TRDizin)

34. Netherton syndrome: Temporary response to dupilumab

Aktas M., Salman A., Apti Sengun O., Comert Ozer E., Hosgoren Tekin S., Akin Cakici O., et al.

PEDIATRIC DERMATOLOGY , cilt.37, sa.6, ss.1210-1211, 2020 (SCI-Expanded, Scopus)

35. Targeted Therapy for Chronic Spontaneous Urticaria: Rationale and Recent Progress

Gimenez-Arnau A. M., Salman A.

DRUGS , cilt.80, sa.16, ss.1617-1634, 2020 (SCI-Expanded, Scopus)

36. Definition, aims, and implementation of GA(2)LEN/HAEi Angioedema Centers of Reference and Excellence

Maurer M., Werner A., Agondi R., Al-Ahmad M., Al-Nesf M. A., Ansotegui I., et al.

ALLERGY , cilt.75, sa.8, ss.2115-2123, 2020 (SCI-Expanded, Scopus)

37. Real-life data on the effectiveness and safety of omalizumab in monotherapy or combined for chronic spontaneous urticaria: a retrospective cohort study

Salman A., ERGUN S. A. T., Maria Gimenez-Arnau A.

JOURNAL OF DERMATOLOGICAL TREATMENT , cilt.31, sa.2, ss.204-209, 2020 (SCI-Expanded, Scopus)

38. Recommendations on the use of systemic treatments for urticaria and atopic dermatitis during the COVID-19 pandemic: Statement of Dermatoallergy Working Group of the Turkish Society of Dermatology

Salman A., Alper S., Atakan N., BÜLBÜL BAŞKAN E., BORLU M., Canpolat F., et al.

TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY , cilt.54, sa.2, ss.71-75, 2020 (ESCI, Scopus, TRDizin)

39. The Real-Life Effectiveness and Safety of Omalizumab Updosing in Patients With Chronic Spontaneous Urticaria

Salman A., Comert E.

JOURNAL OF CUTANEOUS MEDICINE AND SURGERY , cilt.23, sa.5, ss.496-500, 2019 (SCI-Expanded, Scopus)

40. The impact of omalizumab on quality of life and its predictors in patients with chronic spontaneous urticaria: Real-life data

Salman A., Demir G., BEKİROĞLU G. N.

DERMATOLOGIC THERAPY , cilt.32, sa.4, 2019 (SCI-Expanded, Scopus)

41. Acute generalized exanthematous pustulosis due to ceftriaxone: Report of a pediatric case with recurrence after positive patch test

Salman A., Yucelten D., Cakici O. A., KEPENEKLİ KADAYİFCİ E.

PEDIATRIC DERMATOLOGY , cilt.36, sa.4, ss.514-516, 2019 (SCI-Expanded, Scopus)

42. "Slime": A trending cause of isothiazolinone contact allergy in children

Salman A., Demir G., Apti O.

CONTACT DERMATITIS , cilt.80, sa.6, ss.409-411, 2019 (SCI-Expanded, Scopus)

43. Advanced Glycation End Products, a Potential Link between Psoriasis and Cardiovascular Disease: A Case-control Study

ERGUN S. A. T., Yazici V., YAVUZ D., Seckin-Gencosmanoglu D., Ozen G., Salman A., et al.

INDIAN JOURNAL OF DERMATOLOGY , cilt.64, sa.3, ss.201-206, 2019 (SCI-Expanded, Scopus)

44. Margin-Controlled, Staged Surgical Excision in the Treatment of High-Risk Basal Cell Carcinomas of the Head and Neck Region

Ucar A. N. D., Kocaaslan F. N. D., Salman A., DEMİRKESEN C., Bayram F. E., Bayramicli M.

JOURNAL OF CUTANEOUS MEDICINE AND SURGERY , cilt.23, sa.3, ss.258-264, 2019 (SCI-Expanded, Scopus)

45. Methylchloroisothiazolinone and methylisothiazolinone contact allergy: A retrospective cohort study from a tertiary dermatology clinic in Turkey

Salman A.

CONTACT DERMATITIS , cilt.80, sa.3, ss.193-194, 2019 (SCI-Expanded, Scopus)

46. Demographic, clinical and treatment characteristics of patients with Kaposi's sarcoma: A single-center study

Salman A., Ozgen Z.

MARMARA MEDICAL JOURNAL , cilt.32, sa.2, ss.86-89, 2019 (ESCI, Scopus, TRDizin)

47. Expanding the differential diagnosis of raccoon eyes: sweet syndrome

Salman A., DEMİR G., Cinel L., Oguzsoy T., Yildizhan G., Ergun T.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY , cilt.33, sa.1, 2019 (SCI-Expanded, Scopus)

48. The efficacy and safety of targeted narrowband UVB therapy: a retrospective cohort study

Esen Salman K., Kivanc Altunay I., Salman A.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.49, sa.2, ss.595-603, 2019 (SCI-Expanded, Scopus, TRDizin)

49. Impact of psoriasis in the quality of life of children, adolescents and their families: a cross-sectional study

Salman A., YÜCELTEN A. D., Sarac E., Saricam M. H., Perdahli-Fis N.

ANAIS BRASILEIROS DE DERMATOLOGIA , cilt.93, sa.6, ss.819-823, 2018 (SCI-Expanded, Scopus)

50. A 5-year Evaluation of the Publications Made in the Field of Dermatology in Turkey

Salman A.

TURK DERMATOLOJI DERGISI-TURKISH JOURNAL OF DERMATOLOGY , cilt.12, sa.3, ss.129-134, 2018 (ESCI, Scopus, TRDizin)

51. Mesalazine-induced bullous fixed drug eruption

Salman A., Gencosmanoglu D. S., Alahdab Y. O., Gimenez-Arnau A. M.

CONTACT DERMATITIS , cilt.79, sa.1, ss.34-35, 2018 (SCI-Expanded, Scopus)

52. Nodular mucinosis of the breast: A rare entity

Salman A., Cinel L., TÜRKÖZ H. K., Akbas G., ERGUN S. A. T.

MARMARA MEDICAL JOURNAL , cilt.31, sa.2, ss.85-87, 2018 (ESCI, Scopus, TRDizin)

53. Acquired progressive lymphangioma: Case report with partial response to imiquimod 5% cream

Salman A., Sarac G., Kuru B. C., Cinel L., YÜCELTEN A. D., ERGUN S. A. T.

PEDIATRIC DERMATOLOGY , cilt.34, sa.6, 2017 (SCI-Expanded, Scopus)

54. Prevalence of obesity in paediatric psoriasis and its impact on disease severity and progression

ERGUN S. A. T., Gencosmanoglu D. S., Karakoc-Aydiner E., Salman A., Tekin B., Bulbul-Baskan E., et al.

AUSTRALASIAN JOURNAL OF DERMATOLOGY , cilt.58, sa.4, 2017 (SCI-Expanded, Scopus)

55. Hidradenitis suppurativa unresponsive to canakinumab treatment: A case report

Tekin B., Salman A., ERGUN S. A. T.

INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY , cilt.83, sa.5, ss.615-617, 2017 (SCI-Expanded, Scopus)

56. Alopecia universalis unresponsive to treatment with tofacinitib: report of a case with a brief review of the literature.

Salman A., Sarac G., Ergun T.

Dermatology online journal , cilt.23, sa.7, 2017 (Scopus)

57. Autoimmune Bullous Disease in Childhood

Salman A., Tekin B., Yucelten D.

INDIAN JOURNAL OF DERMATOLOGY , cilt.62, sa.4, ss.446-450, 2017 (SCI-Expanded, Scopus)

58. Efficacy, safety and drug survival of conventional agents in pediatric psoriasis: A multicenter, cohort study

ERGUN S. A. T., SEÇKİN GENÇOSMANOĞLU D., ALPSOY E., Bulbul-Baskan E., ERKAYMAN M. H., Salman A., et al.

JOURNAL OF DERMATOLOGY , cilt.44, sa.6, ss.630-634, 2017 (SCI-Expanded, Scopus)

59. Melanoniquia longitudinal

Salman A., Eser A., ATAGÜNDÜZ I., Ergun T.

ACTAS DERMO-SIFILIOGRAFICAS , cilt.108, sa.5, ss.469-470, 2017 (ESCI, Scopus)

60. Infliximab-induced cutaneous eruption resembling pityriasis rubra pilaris in a patient with Takayasu's arteritis

Salman A., Sonmez Y., Sahin H., Unal A. U., DİRESKENELİ R. H., Cinel L., et al.

DERMATOLOGIC THERAPY , cilt.30, sa.3, 2017 (SCI-Expanded, Scopus)

61. Autoimmune progesterone dermatitis mimicking fixed drug eruption

Salman A., ERGUN S. A. T.

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT , cilt.15, sa.2, ss.219-220, 2017 (SCI-Expanded, Scopus)

62. Autoimmun-Progesteron-Dermatitis, die ein fixes Arzneimittelexanthem vortäuscht

Salman A., Ergun T.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG , cilt.15, sa.2, ss.217-219, 2017 (SCI-Expanded, Scopus)

63. Tumor necrosis factor-alpha inhibitors for the treatment of psoriasis patients with liver cirrhosis: A report of four cases with a literature review

ERGUN S. A. T., Seckin-Gencosmanoglu D., Salman A., Qzgen Z., Ocak E. S., Avsar E., et al.

INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY , cilt.83, sa.1, ss.55-59, 2017 (SCI-Expanded, Scopus)

64. Bullous Sweet's Syndrome: Report of an Atypical Case Presenting with Ring-Like, Figurate Lesions

Salman A., Berenjian A., Eser A., Kaymakci F. D., Cinel L., Atagunduz I. K., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.34, sa.1, ss.118-119, 2017 (SCI-Expanded, Scopus, TRDizin)

65. Panniculitis in juvenile dermatomyositis: Report of a case and review of the published work

Salman A., KASAPÇOPUR Ö., ERGUN S. A. T., Durmus Ucar A. N., Demirkesen C.

JOURNAL OF DERMATOLOGY , cilt.43, sa.8, ss.951-953, 2016 (SCI-Expanded, Scopus)

66. Another adverse effect of vemurafenib: Gingival hyperplasia

Salman A., Tekin B., Koca S., Akgul Babacan N., Yumuk P. F., ERGUN S. A. T.

JOURNAL OF DERMATOLOGY , cilt.43, sa.6, ss.706-707, 2016 (SCI-Expanded, Scopus)

67. Social Anxiety and Quality of Life in Vitiligo and Acne Patients with Facial Involvement: A Cross-Sectional Controlled Study

Salman A., Kurt E., Topcuoglu V., Demircay Z.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY , cilt.17, sa.3, ss.305-311, 2016 (SCI-Expanded, SSCI, Scopus)

68. Atypical presentations of eosinophilic fasciitis

ERGUN S. A. T., Seckin D., Salman A., Ocak E. S., YÜCELTEN A. D., DİRESKENELİ R. H., et al.

INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY , cilt.82, sa.1, ss.47-52, 2016 (SCI-Expanded, Scopus)

69. Concurrence of immune thrombocytopenic purpura and alopecia areata: A rare association

Salman A., Eser A.

International Journal of Trichology , cilt.8, sa.1, ss.52-53, 2016 (Scopus)

70. Successful treatment of pityriasis lichenoides chronica with narrow-band ultraviolet B therapy in a patient with keratitis-ichthyosis-deafness syndrome: A case report

Salman A., Gencosmanoglu D. S., YÜCELTEN A. D., ELÇİOĞLU H. N., Richard G., Demirkesen C.

Dermatology Online Journal , cilt.22, sa.5, 2016 (Scopus)

71. Neonatal lupus erythematosus: Report of a case with cutaneous, hematological and hepatobiliary findings

Salman A., Saricam M. H., YÜCELTEN A. D., Demirkesen C., ERGUN S. A. T.

TURKISH JOURNAL OF PEDIATRICS , cilt.58, sa.1, ss.106-108, 2016 (SCI-Expanded, Scopus, TRDizin)

72. Facial discoid dermatosis: A further case of a novel entity

Salman A., Tekin B., Berenjian A., Cinel L., Demirkesen C.

JOURNAL OF DERMATOLOGY , cilt.42, sa.11, ss.1132-1133, 2015 (SCI-Expanded, Scopus)

73. Unilateral cutaneous vasculitis: An uncommon presentation and a possible explanation

Tekin B., Salman A., TUĞLULAR Z. S., Guler D., Ozen G., Direskeneil H., et al.

INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY , cilt.81, sa.5, ss.518-519, 2015 (SCI-Expanded, Scopus)

74. Symmetrical fusiform swellings around the proximal interphalangeal joints.

Saricam M. H., Salman A., Yucelten A. D.

Dermatology practical & conceptual , cilt.5, sa.3, ss.53-4, 2015 (Hakemli Dergi)

75. Cutaneous leishmaniasis mimicking verrucous carcinoma: A case with an unusual clinical course

Salman A., YÜCELTEN A. D., Seckin D., ERGUN S. A. T., Demircay Z.

INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY , cilt.81, sa.4, 2015 (SCI-Expanded, Scopus)

76. Erlotinib induced ectropion following papulopustular rash

Salman A., ÇERMAN E., Seckin D., Kanitez M.

JOURNAL OF DERMATOLOGICAL CASE REPORTS , cilt.9, sa.2, ss.45-47, 2015 (ESCI, Scopus)

77. Efficacy of Narrowband Ultraviolet B Therapy in Pityriasis Lichenoides

Sarac E., Salman A., Yazici V., Seckin D.

MARMARA MEDICAL JOURNAL , cilt.24, sa.2, ss.82-87, 2011 (ESCI, Scopus, TRDizin)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 7

1. Dupilumab treatment in adult patients with moderate to severe atopic dermatitis: A real-world single-center experience from Turkey

Salman A., Aktas M., Ozkurkcu E., Sarac G., Taskapan O., ERGUN S. A. T.

Meeting of the American-Academy-of-Dermatology (AAD), ELECTR NETWORK, 12 - 14 Haziran 2020, cilt.83, (Özet Bildiri)

2. Kronik spontan ürtikeri beraber tedavi edelim

SALMAN A.

Hastalıkta ve Sağlıkta Dermatoloji-Online Kongre, Türkiye, 12 - 15 Eylül 2020

3. Pediatric quality index, family quality index in psoriasis

SALMAN A.

5th International Dermatology and Cosmetology Congress, 12 - 15 Mart 2020

4. Lupus erythematosus panniculitis treated with stromal vascular fraction

ERGUN S. A. T., Ozkan M. C., Salman A.

Annual Meeting of the American-Academy-of-Dermatology, Florida, Amerika Birleşik Devletleri, 3 - 07 Mart 2017, cilt.76, (Özet Bildiri)

5. Human lung tumor cells modifies rates of CD4+CD25+T regulatory, CD19+CD23+B regulatory cells, CD3+CD95+cells, NK cells and B lymphocytes

Kiran B., Fakultesi T., Binasi T. B., TURNA A., Yener A., Gurses A., et al.

7th Annual Meeting of the Federation-of-Clinical-Immunology-Societies, California, Amerika Birleşik Devletleri, 7 - 11 Haziran 2007, cilt.123, (Özet Bildiri)

6. Human lung tumor cells modifles rates of CD4+CD25+T regulatory, CD1 9+CD23+B regulatory cells, CD3+CD95+cells, NK cells and B lymphocytes

Kiran B., Fakultesi T., TURNA A., Yener A., Gurses A., Salman A., et al.

7th Annual Meeting of the Federation-of-Clinical-Immunology-Societies, California, Amerika Birleşik Devletleri, 7 - 11 Haziran 2007, cilt.123, (Özet Bildiri)

7. Human lung tumor cells modifies rates of CD4+CD25+T regulatory, CD19+CD23+B regulatory cells, CD3+CD95+cells, NK cells and B lymphocytes

Kiran B., TURNA A., Yener A., Gurses A., Salman A., Badur S.

7th Annual Meeting of the Federation-of-Clinical-Immunology-Societies, California, Amerika Birleşik Devletleri, 7 - 11 Haziran 2007, cilt.123, (Özet Bildiri)

Kitaplar 21

Yayınlar & Eserler